DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 01 · Volume 34 · January 2001 DOI: 10.1055/s-002-1002

Mini-Review

1
Laux, G.: Cost-Benefit Analysis of Newer versus Older Antidepressants

Original Paper

6
Riedel-Heller, S. G.; Matschinger, H.; Schork, A.; Angermeyer, M. C.: The Utilization of Antidepressants in Community-Dwelling and Institutionalized Elderly - Results from a Representative Survey in Germany
13
van Hyfte, D. M. H.; de Vries Robbé, P. F.; Tjandra-Maga, T. B.; van der Maas, A. A. F.; Zitman, F. G.: Towards a More Rational Use of Psychoactive Substances in Clinical Practice
19
Müller-Vahl, K. R.; Koblenz, A.; Jöbges, M.; Kolbe, H.; Emrich, H. M.; Schneider, U.: Influence of Treatment of Tourette Syndrome with Δ9-Tetrahydrocannabinol (Δ9-THC) on Neuropsychological Performance
25
Hesslinger, B.; Walden, J.; Normann, C.: Acute and Long-Term Treatment of Catatonia with Risperidone
27
Müller, M. J.; Härtter, S.; Köhler, D.; Hiemke, Ch.: Serum Levels of Sulpiride Enantiomers after Oral Treatment with Racemic Sulpiride in Psychiatric Patients: a Pilot Study
33
Ulrich, S.; Northoff, G.; Wurthmann, C.; Partscht, G.; Pester, U.; Herscu, H.; Meyer, F. P.: Serum Levels of Amitriptyline and Therapeutic Effect in Non-Delusional Moderately to Severely Depressed In-Patients: a Therapeutic Window Relationship

Case Report

41
Deuschle, M.; Lederbogen, F.: Benzodiazepine Withdrawal - Induced Catatonia

Letter to the Editor

43
Soyka, M.: Antipsychotic Treatment of Schizophrenics at Risk for Violence